Cortronix Biomedical Advancement Technologies Inc.: key financial figures for fiscal year 2013 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2013)
- -$439.2K
- Total Assets (FY2013)
- $85.4K
- Total Equity (FY2013)
- -$1.1M
- Cash Flows from Operating Activities (FY2013)
- -$278.6K
Source: Cortronix Biomedical Advancement Technologies Inc. 10-K filing (FY2013). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
